Skip to main content

CD8+ T cells: mechanistic target of rapamycin and eukaryotic initiation factor 2 in elite HIV-1 control.

Publication ,  Journal Article
Nyanhete, T; Tomaras, GD
Published in: AIDS
November 28, 2018

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

AIDS

DOI

EISSN

1473-5571

Publication Date

November 28, 2018

Volume

32

Issue

18

Start / End Page

2835 / 2838

Location

England

Related Subject Headings

  • Virology
  • Sirolimus
  • Metabolic Networks and Pathways
  • Humans
  • HIV-1
  • HIV Infections
  • Eukaryotic Initiation Factor-2
  • CD8-Positive T-Lymphocytes
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Nyanhete, T., & Tomaras, G. D. (2018). CD8+ T cells: mechanistic target of rapamycin and eukaryotic initiation factor 2 in elite HIV-1 control. AIDS, 32(18), 2835–2838. https://doi.org/10.1097/QAD.0000000000002008
Nyanhete, Tinashe, and Georgia D. Tomaras. “CD8+ T cells: mechanistic target of rapamycin and eukaryotic initiation factor 2 in elite HIV-1 control.AIDS 32, no. 18 (November 28, 2018): 2835–38. https://doi.org/10.1097/QAD.0000000000002008.
Nyanhete, Tinashe, and Georgia D. Tomaras. “CD8+ T cells: mechanistic target of rapamycin and eukaryotic initiation factor 2 in elite HIV-1 control.AIDS, vol. 32, no. 18, Nov. 2018, pp. 2835–38. Pubmed, doi:10.1097/QAD.0000000000002008.

Published In

AIDS

DOI

EISSN

1473-5571

Publication Date

November 28, 2018

Volume

32

Issue

18

Start / End Page

2835 / 2838

Location

England

Related Subject Headings

  • Virology
  • Sirolimus
  • Metabolic Networks and Pathways
  • Humans
  • HIV-1
  • HIV Infections
  • Eukaryotic Initiation Factor-2
  • CD8-Positive T-Lymphocytes
  • 42 Health sciences
  • 32 Biomedical and clinical sciences